ClinicalTrials.gg
RecruitingNCT06996990Updated Sep 24, 2026

Injury Risk Factors in Volleyball Players

An observational study in Injury;Sports and Athletic Injuries, sponsored by Izmir Democracy University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Days and older. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Izmir Democracy University · Observational

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
18
Ages
18 Days and older
Sex
All
01

Study summary

The aim of this study is to examine the relationship between injury risk and pain, fatigue, muscle strength, balance and quality of life in volleyball players. In this context, it will be investigated how the pain and fatigue levels experienced by volleyball players interact with muscle strength and balance and how these factors increase the risk of injury.

Read the detailed description

Musculoskeletal injuries are highly prevalent among volleyball players and this may be due to the interaction of various physical and subjective factors. Although some risk factors such as muscle strength and balance have been previously investigated, there is limited data on how these parameters together relate to injury risk and athlete health. In this cross-sectional study, standardized tests and self-report questionnaires will be administered to a sample of competitive volleyball players.

02

Conditions studied

  • Injury;Sports
  • Athletic Injuries

Keywords

  • Pain
  • Fatigue
  • Muscle Strength
  • Balance
  • Quality of Life
  • Volleyball
  • Sport Injury
03

In context

Athletic Injuries

258 studies on the registry are indexed under Athletic Injuries; 45 are open to participants now.

This study's planned enrollment of 18 is below the median of 100 across 91 observational studies indexed under Athletic Injuries.

Browse Athletic Injuries studies →

Lead sponsor

Izmir Democracy University is the lead sponsor of 78 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Days and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The population of the research consists of elite athletes and the sample of the research consists of elite volleyball players who volunteered to participate in the research. In our research, there is only one research group consisting of elite volleyball players and there are at least 28 volleyball players.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be over 18 years old and volunteer
  • Have not had any upper or lower extremity injuries in the last 3 months
  • Have not had any upper or lower extremity surgery in the last 6 months
  • Play volleyball professionally

Exclusion criteria

Exclusion Criteria:

  • Having had a lower or upper extremity injury in the last 3 months
  • Having had upper or lower extremity surgery in the last 6 months
  • Being pregnant
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
18 participants (estimated)
Patient registry
No

Groups and cohorts

  • Volleyball Players

    This group will consist of active volleyball players competing at a regional or national level. Participants will undergo one-time assessments including muscle strength, balance, fatigue, pain levels, and quality of life.

    Other: Physical evaluations in Volleyball Players

Interventions

  • OtherPhysical evaluations in Volleyball Players

    This study will evaluate pain, fatigue, muscle strength, balance and quality of life in volleyball players. All these measurements will be completed in two sessions lasting 45-60 minutes.

06

What researchers measure

Primary outcomes

  1. Injury risc assessment

    The Functional Movement Screening Test will be used to assess injury risc in athletes. Seven exercises are used in this test. Each movement is scored on a scale from 0 to 3, with a maximum total score of 21. As the score from this test increases, the risk of injury decreases.

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Pain intensity evaluation

    Pain intensity will be assessed using the Numerical Rating Scale, where participants rate their pain intensity from 0 (no pain) to 10 (maximum pain).

    Time frame: through study completion, an average of 1 year

  2. Fatigue assessment

    The Perceived Physical and Cognitive Fatigue Scale will be used to assess athletes' physical and cognitive fatigue. The scale has 19 items, scored ranging from 19 to 95. Higher scores indicate increased perceived fatigue levels.

    Time frame: through study completion, an average of 1 year

  3. Muscle Strength Measurement

    The lower extremity muscle strength of athletes will be assessed using isokinetic test. Each maximal voluntary contraction will involve the athlete contracting as hard and as fast as possible from full extension to full flexion.Higher values indicate better muscle strength.

    Time frame: through study completion, an average of 1 year

  4. Hand Grip Strength measurement

    Hand grip strength will be assessed using a hand dynamometer. Participants will perform three trials on each hand . The maximum grip strength value for each hand will be analysed.

    Time frame: through study completion, an average of 1 year

  5. Respiratory Muscle Strength measurement

    Respiratory muscle strength will be evaluated using a spirometer. Athletes will perform maximal inspiration (Müller maneuver) and expiration (Valsalva maneuver) to obtain measurements. The highest value will be used for analysis.

    Time frame: through study completion, an average of 1 year

  6. Cough force measurement

    Cough force will be assessed using a peak flow meter. The highest value of three attempts will be recorded. The high value obtained indicates good cough strength.

    Time frame: through study completion, an average of 1 year

  7. Balance evaluation

    Balance will be assessed using the Y-Balance Test, and the average distance reached will be recorded.

    Time frame: through study completion, an average of 1 year

  8. Quality of Life (SF-36 or WHOQOL-BREF)

    The Short Form-36 (SF-36) will be used to assess quality of life. total score is scored from 0 (poorest health) to 100 (best health), with higher scores indicating better health status.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Soylu, Ç., Altundağ, E., Akarçeşme, C., & Ün Yildirim, N. (2020). The relationship between isokinetic knee flexion and extension muscle strength, jump performance, dynamic balance and injury risk in female volleyball players.
  • Wilkosz P, Kabacinski J, Mackala K, Murawa M, Ostarello J, Rzepnicka A, Szczesny L, Fryzowicz A, Maczynski J, Dworak LB. Isokinetic and Isometric Assessment of the Knee Joint Extensors and Flexors of Professional Volleyball Players. Int J Environ Res Public Health. 2021 Jun 24;18(13):6780. doi: 10.3390/ijerph18136780. PubMed 34202540 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for May 2027, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 16, 2025
First posted
May 30, 2025
StartActual
May 30, 2025
Primary completionEst.
May 15, 2027
CompletionEst.
May 15, 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06996990
Lead sponsor
Izmir Democracy University
Responsible party
Gulsah Bargi (Principal Investigator, Izmir Democracy University) — Principal investigator
First posted
May 30, 2025
Start date
May 30, 2025
Primary completion
May 15, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Gülşah Barğı, Assoc Prof
Contact
gulsahbargi35@gmail.com
+90 232 299 0739
Rümeysa Binici, PT
Contact
rumeysa.biniicii@gmail.com
+90 553 230 1529
Gülşah Barğı, Assoc Prof
study director · Izmir Democracy University
Rümeysa Binici, PT
principal investigator · Aras KArgo Volleyball Club
Güfat Arslan, MD
principal investigator · Izmir City Hospital
Uygar Kaya, PT
principal investigator · Göztepe Volleyball Club

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion